Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Kinetic Muscles Receives Phase 2 Grant

By Drug Discovery Trends Editor | April 5, 2010

Kinetic Muscles Inc., a leading innovator of neurorehabilitation technology, announced it has received a 2-year Phase 2 SBIR grant to study a new treatment for veterans returning from active duty with traumatic brain injury (TBI).

Promising results from a Phase 1 study which combined neuropsychological therapy and digital gaming technology led the DoD to fund this Phase 2 study that will validate effectiveness of the therapy system through clinical testing in VA hospitals.

KMI will collaborate with Emory University, Division of Neuropsychology (Atlanta, GA), the DoD, the VA, and the University of Advancing Technology (Tempe, AZ) which is recognized as one of the foremost ‘gaming’ schools in the nation.

TBI is not only the most prevalent injury affecting today’s soldiers, but is also a major health issue for the general population. The Centers for Disease Control and Prevention (CDC -TBI) report that 1.7 million Americans are affected by traumatic brain injury each year and there are 5.3 million people with permanent TBI-related disability in the United States.

Clinical studies have shown that videogame-based therapies such as those used in KMI’s Hand Mentor can improve cognitive ability, dexterity, memory, thought processing, and reasoning. Therapy interventions incorporating both state-of-the-art gaming technology and cutting edge cognitive and motor rehabilitation strategies have the potential to be cost-effective and engaging particularly for a generation of soldiers who have grown up using videogames for entertainment.

“Treatment of TBI builds upon KMI’s neurotherapy technology platform,” said Ed Koeneman, Chief Operating Officer at KMI and Principal Investigator for the study. “Patients with stroke and TBI experience similar cognitive and movement deficits. KMI technology addresses rehabilitation for both groups through repetitive training of specific tasks.”

David Bolman, Provost of the University of Advancing Technology, added, “We are pleased to work with KMI and Emory University on this important project. This collaboration is representative of the merging of technologies that will shape healthcare in the future.”

Date: April 5, 2010
Source: Kinetic Muscles Inc. 


Filed Under: Drug Discovery

 

Related Articles Read More >

Lokavant’s Spectrum v15 uses AI to cut trial-feasibility modeling from weeks to minutes
Prime time for peptide-based drug discovery 
Why smaller, simpler molecular glues are gaining attention in drug discovery
Glass vial, pipette and woman scientist in laboratory for medical study, research or experiment. Test tube, dropper and professional female person with chemical liquid for pharmaceutical innovation
Unlocking ‘bench-to-bedside’ discoveries requires better data sharing and collaboration
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE